Shire PLC (LON:SHP)‘s stock had its “overweight” rating reiterated by stock analysts at J P Morgan Chase & Co in a research report issued on Thursday.

SHP has been the topic of a number of other reports. Goldman Sachs Group, Inc. (The) reiterated a “buy” rating and issued a GBX 6,800 ($88.80) price objective on shares of Shire PLC in a research report on Wednesday, April 12th. Liberum Capital restated a “hold” rating and issued a GBX 4,900 ($63.99) target price on shares of Shire PLC in a research note on Wednesday, June 14th. Barclays PLC restated an “overweight” rating and issued a GBX 6,300 ($82.27) target price on shares of Shire PLC in a research note on Tuesday, June 27th. Deutsche Bank AG restated a “buy” rating and issued a GBX 6,300 ($82.27) target price on shares of Shire PLC in a research note on Wednesday, May 3rd. Finally, BNP Paribas restated an “outperform” rating and issued a GBX 5,900 ($77.04) target price on shares of Shire PLC in a research note on Wednesday, March 22nd. Three investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of GBX 6,024 ($78.66).

Shire PLC (LON:SHP) opened at 4156.50 on Thursday. The firm’s market capitalization is GBX 37.58 billion. The firm has a 50-day moving average price of GBX 4,323.12 and a 200 day moving average price of GBX 4,580.36. Shire PLC has a 52 week low of GBX 4,025.00 and a 52 week high of GBX 5,377.00.

COPYRIGHT VIOLATION NOTICE: “Shire PLC (SHP) Given Overweight Rating at J P Morgan Chase & Co” was reported by Daily Political and is owned by of Daily Political. If you are reading this piece on another publication, it was illegally copied and republished in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.dailypolitical.com/2017/07/21/shire-plc-shp-given-overweight-rating-at-j-p-morgan-chase-co.html.

In other Shire PLC news, insider Dominic Blakemore bought 152 shares of Shire PLC stock in a transaction on Friday, June 30th. The stock was acquired at an average price of GBX 4,255 ($55.56) per share, with a total value of £6,467.60 ($8,445.55).

About Shire PLC

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

Analyst Recommendations for Shire PLC (LON:SHP)

Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.